Literature DB >> 10228293

Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated.

B Bin-Abbas1, F A Conte, M M Grumbach, S L Kaplan.   

Abstract

Micropenis is commonly due to fetal testosterone deficiency. The clinical management of this form of micropenis has been contentious, with disagreement about the capacity of testosterone treatment to induce a functionally adequate adult penis. As a consequence, some clinicians recommend sex reversal of affected male infants. We studied 8 male subjects with micropenis secondary to congenital pituitary gonadotropin deficiency from infancy or childhood to maturity (ages 18 to 27 years). Four patients were treated with testosterone before 2 years of age (group I) and four between age 6 and 13 years (group II). At presentation, the mean penile length in group I was 1.1 cm (-4 SD; range, 0.5 to 1.5 cm) and in group II it was 2.7 cm (-3.4 SD; range, 1.5 to 3.5 cm). All patients received one or more courses of 3 intramuscular injections of testosterone enanthate (25 or 50 mg) at 4-week intervals in infancy or childhood. At the age of puberty the dose was gradually increased to 200 mg monthly and later to an adult replacement regimen. As adults, both group I and II had attained a mean final penile length of 10.3 cm 2.7 cm with a range of 8 to 14 cm (mean adult stretched penile length for Caucasians is 12.4 2.7 cm). Six of 8 men were sexually active, and all reported normal male gender identity and psychosocial behavior. We conclude that 1 or 2 short courses of testosterone therapy in infancy and childhood augment penile size into the normal range for age in boys with micropenis secondary to fetal testosterone deficiency; replacement therapy at the age of puberty results in an adult size penis within 2 SD of the mean. We found no clinical, psychologic, or physiologic indications to support conversion of affected male infants to girls. Further, the results of this study do not support the notion, derived from data in the rat, that testosterone treatment in infancy or childhood impairs penile growth in adolescence and compromises adult penile length.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228293     DOI: 10.1016/s0022-3476(99)70244-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  34 in total

1.  The child with micropenis.

Authors:  P S Menon; U A Khatwa
Journal:  Indian J Pediatr       Date:  2000-06       Impact factor: 1.967

2.  Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth.

Authors:  William G Reiner; John P Gearhart
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

Review 3.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

4.  Long-term psychosocial adjustments, satisfaction related to gender and the family equations in disorders of sexual differentiation with male sex assignment.

Authors:  Deepika Gupta; Madhu Bhardwaj; Shilpa Sharma; A C Ammini; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2010-10       Impact factor: 1.827

Review 5.  Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma.

Authors:  A D Fisher; J Ristori; E Fanni; G Castellini; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2016-06-10       Impact factor: 4.256

6.  Gender identity and sex-of-rearing in children with disorders of sexual differentiation.

Authors:  William G Reiner
Journal:  J Pediatr Endocrinol Metab       Date:  2005-06       Impact factor: 1.634

Review 7.  The inconspicuous penis in children.

Authors:  Marcello Cimador; Pieralba Catalano; Rita Ortolano; Mario Giuffrè
Journal:  Nat Rev Urol       Date:  2015-04-07       Impact factor: 14.432

Review 8.  Hypopituitarism.

Authors:  Paola Ascoli; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

9.  Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes.

Authors:  Flavia Amanda Costa-Barbosa; Ravikumar Balasubramanian; Kimberly W Keefe; Natalie D Shaw; Nada Al-Tassan; Lacey Plummer; Andrew A Dwyer; Cassandra L Buck; Jin-Ho Choi; Stephanie B Seminara; Richard Quinton; Dorota Monies; Brian Meyer; Janet E Hall; Nelly Pitteloud; William F Crowley
Journal:  J Clin Endocrinol Metab       Date:  2013-03-26       Impact factor: 5.958

10.  Critical androgen-sensitive periods of rat penis and clitoris development.

Authors:  Michelle Welsh; David J MacLeod; Marion Walker; Lee B Smith; Richard M Sharpe
Journal:  Int J Androl       Date:  2009-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.